Regulatory T cells protect from local and systemic bone destruction in arthritis

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 7238-7246

  Zaiss, Mario M ^a   Frey, Benjamin ^a   Hess, Andreas ^a   Zwerina, Jochen ^a   Luther, Julia ^a   Nimmerjahn, Falk ^a   Engelke, Klaus ^a   Kollias, George ^c   Hünig, Thomas ^b   Schett, Georg ^a   David, Jean Pierre ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SUPERAGONIST CD28; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DESTRUCTION; CELL DIFFERENTIATION; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; WILD TYPE; ANIMAL; ARTHRITIS; C57BL MOUSE; CELL SEPARATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BONE RESORPTION; CELL DIFFERENTIATION; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOCLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953639101     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903841     Document Type: Article

References (43)

1. McInnes, I. B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7: 429-442.
2. Gravallese, E. M. 2002. Bone destruction in arthritis. Ann. Rheum. Dis. 61 (Suppl. 2): ii84-ii86.
3. Schett, G., and S. L. Teitelbaum. 2009. Osteoclasts and Arthritis. J. Bone Miner. Res. 24: 1142-1146.
4. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, and G. Kollias. 1991. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10: 4025-4031. (Pubitemid 21905432)
5. David, J. P. 2007. Osteoimmunology: a view from the bone. Adv. Immunol. 95: 149-165.
6. Horton, J. E., L. G. Raisz, H. A. Simmons, J. J. Oppenheim, and S. E. Mergenhagen. 1972. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 177: 793-795.
7. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
8. Horwood, N. J., V. Kartsogiannis, J. M. Quinn, E. Romas, T. J. Martin, and M. T. Gillespie. 1999. Activated T lymphocytes support osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 265: 144-150.
9. Choi, Y., K. M. Woo, S. H. Ko, Y. J. Lee, S. J. Park, H. M. Kim, and B. S. Kwon. 2001. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Eur. J. Immunol. 31: 2179-2188.
10. Dai, S. M., H. Matsuno, H. Nakamura, K. Nishioka, and K. Yudoh. 2004. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 50: 432-443.
11. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408: 600-605.
12. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673-2682.
13. Koshy, P. J., N. Henderson, C. Logan, P. F. Life, T. E. Cawston, and A. D. Rowan. 2002. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann. Rheum. Dis. 61: 704-713.
14. Chabaud, M., J. M. Durand, N. Buchs, F. Fossiez, G. Page, L. Frappart, and P. Miossec. 1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42: 963-970. (Pubitemid 29215007)
15. Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352.
16. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
17. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
18. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200: 277-285.
19. Valencia, X., G. Stephens, R. Goldbach-Mansky, M. Wilson, E. M. Shevach, and P. E. Lipsky. 2006. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108: 253-261.
20. Boissier, M. C., E. Assier, G. Falgarone, and N. Bessis. 2008. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 75: 373-375.
21. Nistala, K., and L. R. Wedderburn. 2009. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford) 48: 602-606.
22. Kelchtermans, H., B. De Klerck, T. Mitera, M. Van Balen, D. Bullens, A. Billiau, G. Leclercq, and P. Matthys. 2005. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res. Ther. 7: R402-R415.
23. Morgan, M. E., R. Flierman, L. M. van Duivenvoorde, H. J. Witteveen, W. van Ewijk, J. M. van Laar, R. R. de Vries, and R. E. Toes. 2005. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52: 2212-2221.
24. Zaiss, M. M., R. Axmann, J. Zwerina, K. Polzer, E. Gückel, A. Skapenko, H. Schulze-Koops, N. Horwood, A. Cope, and G. Schett. 2007. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56: 4104-4112.
25. Khattri, R., D. Kasprowicz, T. Cox, M. Mortrud, M. W. Appleby, M. E. Brunkow, S. F. Ziegler, and F. Ramsdell. 2001. The amount of scurfin protein determines peripheral T cell number and responsiveness. J. Immunol. 167: 6312-6320. (Pubitemid 33081562)
26. Wachsmuth, L., and K. Engelke. 2004. High-resolution imaging of osteoarthritis using microcomputed tomography. Methods Mol. Med. 101: 231-248.
27. Redlich, K., S. Hayer, R. Ricci, J. P. David, M. Tohidast-Akrad, G. Kollias, G. Steiner, J. S. Smolen, E. F. Wagner, and G. Schett. 2002. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J. Clin. Invest. 110: 1419-1427.
28. Dennehy, K. M., F. Elias, G. Zeder-Lutz, X. Ding, D. Altschuh, F. Lühder, and T. Hünig. 2006. Cutting edge: monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses. J. Immunol. 176: 5725-5729.
29. Gogishvili, T., D. Langenhorst, F. Lühder, F. Elias, K. Elflein, K. M. Dennehy, R. Gold, and T. Hünig. 2009. Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS ONE 4: e4643.
30. Schett, G., K. Redlich, S. Hayer, J. Zwerina, B. Bolon, C. Dunstan, B. Görtz, A. Schulz, H. Bergmeister, G. Kollias, et al. 2003. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum. 48: 2042-2051. (Pubitemid 36828700)
31. van Amelsfort, J. M., K. M. Jacobs, J. W. Bijlsma, F. P. Lafeber, and L. S. Taams. 2004. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50: 2775-2785.
32. Cao, D., R. van Vollenhoven, L. Klareskog, C. Trollmo, and V. Malmström. 2004. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6: R335-R346.
33. Nadkarni, S., C. Mauri, and M. R. Ehrenstein. 2007. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med. 204: 33-39.
34. Lin, C. H., and T. Hünig. 2003. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 33: 626-638.
35. Beyersdorf, N., S. Gaupp, K. Balbach, J. Schmidt, K. V. Toyka, C. H. Lin, T. Hanke, T. Hünig, T. Kerkau, and R. Gold. 2005. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J. Exp. Med. 202: 445-455.
36. Morgan, M. E., R. P. Sutmuller, H. J. Witteveen, L. M. van Duivenvoorde, E. Zanelli, C. J. Melief, A. Snijders, R. Offringa, R. R. de Vries, and R. E. Toes. 2003. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48: 1452-1460.
37. Nguyen, L. T., J. Jacobs, D. Mathis, and C. Benoist. 2007. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56: 509-520. (Pubitemid 46271977)
38. Hayer, S., G. Steiner, B. Görtz, E. Reiter, M. Tohidast-Akrad, M. Amling, O. Hoffmann, K. Redlich, J. Zwerina, K. Skriner, et al. 2005. CD44 is a determinant of inflammatory bone loss. J. Exp. Med. 201: 903-914.
39. Kelchtermans, H., L. Geboes, T. Mitera, D. Huskens, G. Leclercq, and P. Matthys. 2009. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann. Rheum. Dis. 68: 744-750.
40. Kim, Y. G., C. K. Lee, S. S. Nah, S. H. Mun, B. Yoo, and H. B. Moon. 2007. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 357: 1046-1052.
41. Flores-Borja, F., E. C. Jury, C. Mauri, and M. R. Ehrenstein. 2008. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 105: 19396-19401.
42. Axmann, R., S. Herman, M. M. Zaiss, S. Franz, K. Polzer, J. Zwerina, M. Herrmann, J. Smolen, and G. Schett. 2008. CTLA-4 directly inhibits osteoclast formation. Ann. Rheum. Dis. 67: 1603-1609.
43. Suntharalingam, G., M. R. Perry, S. Ward, S. J. Brett, A. Castello-Cortes, M. D. Brunner, and N. Panoskaltsis. 2006. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355: 1018-1028.